Adults with relapsing MS rated the Sensoready pen, an autoinjector used to self-administer Kesimpta, for ease of use and ...

According to the National Cancer Institute, approximately 40.5% of Americans will be diagnosed with cancer at some point ...

The following is a summary of “Real-world satisfaction and experience with injection and autoinjector device for ofatumumab ...

Cosmos Health Inc. ("Cosmos Health" or the "Company")(NASDAQ:COSM) , a diversified, vertically integrated global healthcare ...

The first clinical consensus statement for managing multiple sclerosis (MS) in Australia and New Zealand has been released, and will help health professionals navigate a treatment landscape that has ...

Researchers have made more advancements in multiple sclerosis in the last five years than in the previous 70 years. Knowing ...